Abstract
Thyroid status was characterized in very preterm infants (gestational age≤32 wk; n = 61) from birth through d 14, and in infants who died within 16 d after delivery (n = 10), where it was also correlated with metabolism of iodothyronines in peripheral tissues (brain, liver, kidney, skeletal muscle, and adipose tissue). At 3 d of life, mean plasma levels of thyroxine, triiodothyronine, and TSH started to decrease, being lower in the critically ill compared with healthy premature neonates. Activities of the three iodothyronine deiodinases enzymes (type I, II, and III, respectively) were detected in all postmortem tissue samples, except for absence of the type II activity in kidney. All activities were the highest in liver and differed in other tissues. Lack of correlation between the type I activity in liver(and kidney), and plasma levels of thyroid hormones suggested that the thyroid was the primary source of circulating triiodothyronine. On the other hand, namely in brain, correlations between activity of the deiodinases and plasma hormone levels were found which suggested a complex control by thyroid hormones of their own metabolism. High activity of type III in liver, adipose tissue, and skeletal muscle demonstrated a role of these tissues in thyroid hormones degradation. Results support the view that peripheral tissues of very preterm infants are engaged in local generation of triiodothyronine, and inactivation of thyroid hormones, but do not represent a major source of circulating triiodothyronine.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- T3:
-
3,5,3′-triiodothyronine
- T4:
-
thyroxine
- rT3:
-
3,3′,5′-triiodothyronine (reverse triiodothyronine)
- 5′D-I:
-
Type I iodothyronine 5′-deiodinase
- 5′D-II:
-
type II iodothyronine 5′deiodinase
- 5D-III:
-
type III 5-deiodinase
- PTU:
-
6-n-propyl-2-thiouracil
References
Fisher DA, Klein AH 1981; Thyroid development and disorders of thyroid function in the newborn. N Engl J Med 304: 702–711.
van Wassenaer AG. Kok JH, Endert E, Vulsma T, de Vijlder JJM 1993; Thyroxine administration to infants of less than 30 wk gestational age does not increase plasma triiodothyronine concentrations. Acta Endocrinol 129: 139–146.
Lucas A. Rennie J, Baker BA, Morley R 1988; Low plasma triiodothyronine concentrations and outcome in preterm infants. Arch Dis Child 63: 1201–1206.
Meijer WJ, Verloove-Vanhorick SP, Brand R, van den Brande JL 1992; Transient hypothyroxinemia associated with developmental delay in very preterm infants. Arch Dis Child 67: 944–947.
Den Ouden AL, Kok JH, Verkerk PH, Brand R, Verloove-Vanhorick SP 1996; The relation between neonatal thyroxine levels and neurodevelopmental outcome at age 5 and 9 years in a national cohort of very preterm and/or very low birth weight infants. Pediatr Res 39: 142–145.
Romaguera J, Ramirez M, Adamsons K 1993; Intra-amniotic thyroxine to accelerate fetal maturation. Semin Perinatol 17: 260–266.
Moya FR, Gross I 1993; Combined hormonal therapy for the prevention of respiratory distress syndrome and its consequences. Semin Perinatol 17: 267–274.
Ballard PL, Ballard RA, Creasy RK, Padbury J, Polk DH, Bracken M, Moya FR, Gross I 1992; Plasma thyroid hormones and prolactin in premature infants and their mothers after prenatal treatment with thyrotropin-releasing hormone. Pediatr Res 32: 673–678.
Larsen R, Ingbar SH 1992; The thyroid gland. In: Wilson JD, Foster DW (eds) Williams Textbook of Endocrinology. WB Saunders, Philadelphia. pp 357–487
Pilo A, Iervasi G, Vitek F, Ferdeghini M, Cazzuola F, Bianchi R 1990; Thyroidal and peripheral production of 3,5,3′-triiodothyronine in humans by multicompartmental analysis. Am J Physiol 1990:E715–E726.
Berry MJ, Banu L, Larsen PR 1991; Type I iodothyronine deiodinase is a selenocysteine-containing enzyme. Nature 349: 438–440.
Campos-Barros A, Hoell T, Musa A, Sampaolo S, Stoltenburg G, Pinna G. Eravci M, Meinhold H, Baumgartner A 1996; Phenolic and tyrosyl ring iodothyronine deiodination and thyroid hormone concentrations in the human central nervous system. J Clin Endocrinol Metab 81: 2179–2185.
Visser TJ 1996; Role of sulfate in thyroid hormone sulfation. Eur J Endocrinol 134: 12–14.
Visser TJ, Kaptein E, Terpstra OT, Krenning EP 1988; Deiodination of thyroid hormone by human liver. J Clin Endocrinol Metab 67: 17–24.
Croteau W, Davey JC, Galton VA, St-Germain DL 1996; Cloning of the mammalian type II iodothyronine deiodinase. A selenoprotein differentially expressed and regulated in human and rat brain and other tissues. J Clin Invest 98: 405–417.
Karmarkar MG, Prabarkaran D, Godbole MM 1993; 5′-Monodeiodinase activity in developing human cerebral cortex. Am J Clin Nutr Suppl 57: 291S–294S.
Houstek J, Vizek K, Pavelka S, Kopecky J, Krjcova E. Hermanska E, Cermakova S 1993; Type II iodothyronine 5′-deiodinase and uncoupling protein in brown adipose tissue of human newborns. J Clin Endocrinol Metab 77: 382–387.
Calvo R, Obregon MJ, Ruiz de Ona C, Escobar del Rey F. Morreale de Escobar G 1990; Congenital hypothyroidism, as studied in rats. Crucial role of maternal thyroxine but not of 3,5,3′-triiodothyronine in the protection of the fetal brain. J Clin Invest 86: 889–899.
Fernandez JA. Mampel T, Villarroya F, Iglesias R 1987; Direct assessment of brown adipose tissue as a site of systemic tri-iodothyronine production in the rat. Biochem J 243: 281–284.
Croteau W. Whittemore SL, Schneider MJ, St-Germain DL 1995; Cloning and expression of cDNA for a mammalian type III deiodinase. J Biol Chem 270: 16569–16575.
Salvatore D, Low SC, Berry M, Maia AL, Harney JW, Croteau W, St-Germain DL, Larsen PR, Type III iodothyronine deiodinase: cloning, in vitro expression, and functional analysis of the placental selenoenzyme. J Clin Invest 96: 2421–2430
St-Germain DL 1994; Biochemical study of type III iodothyronine deiodinase. In: Wu S-Y, Visser TJ (eds) Thyroid Hormone Metabolism: Molecular Biology and Alternative Pathways. CRC Press, Ann Arbor, MI, 45–66.
Merklin RJ 1974; Growth and distribution of human fetal brown fat expression, and functional analysis of the placental selenoenzyme. Anat Rec 178: 637–645.
Kopecký J, Sigurdson L, Park IR, Himms Hagen J 1986; Thyroxine 5′-deiodinase in hamster and rat brown adipose tissue: effect of cold and diet. Am J Physiol 251:E1–E7.
Lubchenco LO, Hansman C, Dressler N, Boyd E 1963; Intrauterine growth as estimated from life-born birth weight data at 24-32 wk of gestation. Pediatrics 32: 793–800.
Penny R. Spencer CA, Frasier SD, Nicoloff JT 1984; Cord serum thyroid-stimulating hormone and thyroglobulin levels decline with increasing birth weight in newborns. J Clin Endocrinol Metab 59: 979–985.
Cavalieri RR, Rapoport B 1977; Impaired peripheral conversion of thyroxine to triiodothyronine. Annu Rev Med 28: 57–65.
Chopra IJ, Solomon DH, Chopra U, Wu SY, Fisher DA, Nakamura Y 1978; Pathways of metabolism of thyroid hormones. Recent Prog Horm Res 34: 521–567.
Marsh TD, Freeman D, McKeown RE, Bowyer FP 1993; Increased mortality in neonates with low thyroxine values. J Perinatol 13: 201–204.
Wu S-Y, Klein AH, Chopra IJ, Fisher DA 1978; Alterations in tissue thyroxine-5′-monodeiodinating activity in perinatal period. Endocrinology 103: 235–239.
Slebodzinski AB, Brzezinska-Slebodzinska E 1994; The appearance and activity of tissue thyroxine 5′- and 5-monodeiodinase during ontogenesis in the fetal pig. J Endocr 141: 243–249.
Chanoine J-P, Veronikis I, Alex S, Stone S, Fang SL, Leonard JL. Braverman LE 1993; The postnatal serum 3,5,3′-triiodothyronine (T3) surge in the rat is largely independent of extrathyroidal 5′-deiodination of thyroxine to T3 . Endocrinology 133: 2604–2609.
Escobar-Morreale HF, Escobar del Rey F, Obregon MJ, Morreale de Escobar G 1996; Only the combined treatment with thyroxine and triiodothyronine ensures euthyroidism in all tissue of the thyroidectomized rat. Endocrinology 137: 2490–2502.
Acknowledgements
The authors thank Jaroslav Vorlíček for statistical consultation.
Author information
Authors and Affiliations
Additional information
Supported by the Grant Agency of the Ministry of Health of the Czech Republic (Grant Z 629-3), and by the Howard Hughes Medical Institute (Grant 75195-541001).
Deceased
Rights and permissions
About this article
Cite this article
Pavelka, S., Kopecký, P., Bendlová, B. et al. Tissue Metabolism and Plasma Levels of Thyroid Hormones in Critically Ill Very Premature Infants. Pediatr Res 42, 812–818 (1997). https://doi.org/10.1203/00006450-199712000-00016
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/00006450-199712000-00016
This article is cited by
-
Effect of levothyroxine supplementation in extremely low birth weight infants with transient hypothyroxinemia of prematurity
Scientific Reports (2022)
-
Initial and delayed thyroid-stimulating hormone elevation in extremely low-birth-weight infants
BMC Pediatrics (2019)
-
Incidence and severity of transient hypothyroxinaemia of prematurity associated with survival without composite morbidities in extremely low birth weight infants
Scientific Reports (2019)
-
Type I iodothyronine 5′-deiodinase mRNA and activity is increased in adipose tissue of obese subjects
International Journal of Obesity (2012)
-
125I-labelled iodothyronines: useful tools for studies of effects of an antidepressant drug fluoxetine in the rat
Journal of Radioanalytical and Nuclear Chemistry (2010)
